Assignment of Assignor's Interest

Recorded: 2016-06-15 Pages: 3

Assignor

LIN, KEVIN

Executed: 2015-01-19

Assignee

CLOVIS ONCOLOGY, INC.

5500 FLATIRON PARKWAY, SUITE 100, BOULDER, COLORADO, 80301

Covered Property (1)

Use of PARP Inhibitors to Treat Breast or Ovarian Cancer Patients Showing a Loss of Heterozygosity

Application: 15/104,684 →

Publication: US 2018/0163271

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.